Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Centro di Riferimento Oncologico - Aviano
Centre Leon Berard
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Region Stockholm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
South Valley University
European Institute of Oncology
Istanbul Medipol University Hospital
McMaster University
Ankara Medipol University
Changhai Hospital
Medipol University
Institut Cancerologie de l'Ouest
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Women's College Hospital
N.N. Petrov National Medical Research Center of Oncology
Association Francaise pour la Recherche Thermale
Institut Català d'Oncologia
University of Strathclyde
The First Affiliated Hospital with Nanjing Medical University
Gazi University
Cairo University
Marmara University
Universitat Jaume I
Georgetown University
Ciusss de L'Est de l'Île de Montréal
Kaiser Permanente
Centre Georges Francois Leclerc
Chungnam National University
Ataturk University
University Hospital, Ghent
Shengjing Hospital
Peking Union Medical College Hospital
University Hospital, Ghent
The Greater Poland Cancer Centre
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Hospital Clinic of Barcelona
University of Seville
Uppsala University
Fondation Hôpital Saint-Joseph
Lund University
Universidad de Granada
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Assistance Publique - Hôpitaux de Paris
The University of Hong Kong
TaiHao Medical Inc.
University of Missouri, Kansas City